Adarza BioSystems Receives $4,000,000 Series A Round

  • Feed Type
  • Date
    10/3/2014
  • Company Name
    Adarza BioSystems
  • Mailing Address
    150 Lucius Gordon Dr. West Henrietta, NY 14586 USA
  • Company Description
    Adarza BioSystems, Inc is an early stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. This technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip.
  • Website
    http://www.adarzabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The latest financing is being used to launch the company’s first 100-plex immunoassay product and accelerate development of highly sensitive plex assays that target biological analytes.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy